The latest closing stock price for Inozyme Pharma as of November 08, 2024 is 4.02.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-771 today, roughly -1 times their original investment - a -30.81% compound annual growth rate over 4 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 7.79, which is 93.8% above the current share price.
The Inozyme Pharma 52-week low stock price is 2.71, which is 32.6% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 4.96.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-771 today, roughly -1 times their original investment - a -30.81% compound annual growth rate over 4 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 7.79, which is 93.8% above the current share price.
The Inozyme Pharma 52-week low stock price is 2.71, which is 32.6% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 4.96.